title: Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study.
abstract: OBJECTIVE
  To analyze the factors associated with mortality, survival and causes of death in patients with systemic lupus erythematosus (SLE) in Argentina.
  
  
  METHODS
  A series of 366 patients with SLE (45 men and 321 women), mean age 29 y (range 11-70 y) and mean disease duration 6 y, was evaluated from 1990 to 1998. A total of 57 clinical, serological and therapeutic variables were studied.
  
  
  RESULTS
  Five- and 10-year survival was 91% and 85% respectively. Forty four patients died (12%): 54% due to sepsis and 32% due to active SLE. Mortality risk factors included heart involvement CRR 3.82), hyperlipidemia (RR 2.72), renal damage (RR 2. 62), infections (RR 2.44), lung disease (RR 2.20) and myositis (RR 2. 07). High-dose prednisone (RR 3.4) or cyclophosphamide (RR 9.19) treatments increased the risk of sepsis (P=0.003) as a cause of death. However, corticosteroids, antimalarial agents and accumulated cyclophosphamide doses proved to be protective factors in overall mortality figures (RR <1).
  
  
  CONCLUSIONS
  The main risk factors of death in SLE were heart involvement, hyperlipidemia and renal damage. Treatment with steroids, antimalarial agents and cyclophosphamide improved survival. High-dose corticosteroids and cyclophosphamide were associated with sepsis as a cause of death.
authors.affiliation: Posgrado de Reumatología, Universidad Nacional de Tucumán, Argentina.
authors.forename: V
authors.initials: V
authors.lastname: Bellomio
authors.forename: A
authors.initials: A
authors.lastname: Spindler
authors.forename: E
authors.initials: E
authors.lastname: Lucero
authors.forename: A
authors.initials: A
authors.lastname: Berman
authors.forename: M
authors.initials: M
authors.lastname: Santana
authors.forename: C
authors.initials: C
authors.lastname: Moreno
authors.forename: R P
authors.initials: RP
authors.lastname: Hidalgo
authors.forename: S
authors.initials: S
authors.lastname: Paira
authors.forename: C
authors.initials: C
authors.lastname: Graf
authors.forename: J A
authors.initials: JA
authors.lastname: Maldonado Cocco
authors.forename: G
authors.initials: G
authors.lastname: Citera
authors.forename: M S
authors.initials: MS
authors.lastname: Arriola
authors.forename: G
authors.initials: G
authors.lastname: Gómez
authors.forename: J C
authors.initials: JC
authors.lastname: Barreira
authors.forename: O
authors.initials: O
authors.lastname: Messina
authors.forename: C
authors.initials: C
authors.lastname: Asnal
authors.forename: D
authors.initials: D
authors.lastname: Carrillo
authors.forename: A
authors.initials: A
authors.lastname: Gervilla
authors.forename: L
authors.initials: L
authors.lastname: García
authors.forename: M
authors.initials: M
authors.lastname: Máscolo
authors.forename: D
authors.initials: D
authors.lastname: De la Sota M
authors.forename: G
authors.initials: G
authors.lastname: Rosso
authors.forename: L F
authors.initials: LF
authors.lastname: Somma
authors.forename: R F
authors.initials: RF
authors.lastname: Sosa
authors.forename: O
authors.initials: O
authors.lastname: Rillo
authors.forename: J A
authors.initials: JA
authors.lastname: Caracciolo
authors.forename: G
authors.initials: G
authors.lastname: Lancioni
authors.forename: A
authors.initials: A
authors.lastname: Gómez
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001118:Argentina / Q000453:epidemiology; D002648:Child; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis